Eternal Limited has informed the Exchange regarding grant of stock options pursuant to approval of nomination and remuneration committee
ETERNAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
On January 1, 2026, Eternal Limited's Nomination and Remuneration Committee approved the grant of 42,901,017 stock options to eligible employees across three ESOP schemes: 19 options under ESOP 2014, 79,00,998 options under ESOP 2021, and 3,50,00,000 options under ESOP 2024. The total number of equity shares covered by these grants, including adjustments from past corporate actions, stands at 43,028,298 shares of face value ₹1 each. The exercise price is nominal at ₹1 per option, and vested options can be exercised within 10 years of vesting (or 12 years from listing for older schemes). Shares issued upon exercise will not be subject to any lock-in period.
This is a routine ESOP allotment disclosure and signals the company's continued use of stock-based compensation to attract and retain talent. The bulk of the grant (about 82%) comes from the new ESOP 2024 scheme, which will lead to gradual future dilution as options vest and are exercised, but the immediate impact on share price is limited.